Revvity
Amarjit (Amo) Saini is an experienced R&D Manager and Innovation Leader currently at Revvity since June 2023, after a brief tenure at PerkinElmer, Inc. In a career spanning over a decade, Amarjit held significant roles including Senior Researcher at Karolinska Institutet, where responsibilities included managing ISO/IEC 17025 certification and leading clinical research in transmedicine. Amarjit's expertise encompasses project management in academic settings, innovative development of diagnostic assays, and mentorship of graduate and doctoral students. Academic qualifications include a Doctor of Philosophy in Regenerative Medicine from The Manchester Metropolitan University and multiple certifications in Good Clinical Practice and regulatory affairs.
This person is not in any teams
This person is not in any offices
Revvity
8 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com